systematic review | Q1504425 |
review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Lana M Chahine | Q57071973 |
Amy W Amara | Q83458162 | ||
P2093 | author name string | Aleksandar Videnovic | |
P2860 | cites work | Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications | Q24234273 |
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study | Q24564550 | ||
'The clocks that time us'--circadian rhythms in neurodegenerative disorders | Q26824646 | ||
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 | ||
Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 | ||
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline | Q28277963 | ||
The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography | Q48497005 | ||
Impaired bed mobility and disordered sleep in Parkinson's disease | Q48497375 | ||
Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study | Q48497382 | ||
Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study | Q48498679 | ||
Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease | Q48501488 | ||
Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepiness | Q48504664 | ||
Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease | Q48504747 | ||
Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease | Q48505608 | ||
REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease | Q48529264 | ||
Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder | Q48534352 | ||
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease | Q48544098 | ||
Clinical usefulness of the Parkinson's disease sleep scale | Q48553049 | ||
Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation | Q48557687 | ||
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study | Q48561454 | ||
Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel | Q48561634 | ||
Association between waking EEG slowing and REM sleep behavior disorder in PD without dementia | Q48602775 | ||
Assessment of sleep and sleepiness in Parkinson disease | Q48603917 | ||
Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east China | Q48099379 | ||
Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder | Q48105938 | ||
Evaluation of sleep disorders in Parkinson's disease: a comparison between physician diagnosis and self-administered questionnaires | Q48110582 | ||
Daytime sleep in Parkinson's disease measured by episodes of immobility | Q48116882 | ||
Clinical REM sleep behavior disorder and motor subtypes in Parkinson's disease: a questionnaire-based study | Q48119243 | ||
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. | Q48125649 | ||
REM sleep behavior disorder in Parkinson disease: association with abnormal ocular motor findings | Q48127661 | ||
Primary sleep disorder prevalence in patients with newly diagnosed Parkinson’s disease | Q48129611 | ||
Sleep disorders in Parkinson's disease: clinical features, iron metabolism and related mechanism | Q28537911 | ||
The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study | Q28727519 | ||
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. | Q30419918 | ||
Excessive daytime sleepiness and subsequent development of Parkinson disease | Q30438636 | ||
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder | Q30493368 | ||
Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. | Q30499904 | ||
Case control polysomnographic studies of sleep disorders in Parkinson's disease | Q31028156 | ||
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease | Q31108254 | ||
The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson's disease | Q31133155 | ||
Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson's disease | Q31144479 | ||
Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. | Q33211624 | ||
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease | Q33607256 | ||
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease | Q33647691 | ||
Best practice guide for the treatment of REM sleep behavior disorder (RBD). | Q33660579 | ||
Sleep in Parkinson's disease: a comparison of actigraphy and subjective measures | Q33808286 | ||
Observations on sleep-disordered breathing in idiopathic Parkinson's disease | Q33812515 | ||
Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease | Q33835856 | ||
Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease | Q33860315 | ||
Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons | Q33957588 | ||
Sleep and circadian rhythm regulation in early Parkinson disease | Q33992743 | ||
Daytime sleepiness and Parkinson's disease: the contribution of the multiple sleep latency test. | Q33999968 | ||
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo | Q34086489 | ||
Daytime sleepiness in Parkinson's disease: a reappraisal | Q34150079 | ||
Alterations in Polysomnographic (PSG) profile in drug-naïve Parkinson's disease | Q34169846 | ||
Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients | Q34195029 | ||
The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis | Q34215776 | ||
Diagnostic thresholds for quantitative REM sleep phasic burst duration, phasic and tonic muscle activity, and REM atonia index in REM sleep behavior disorder with and without comorbid obstructive sleep apnea | Q34238320 | ||
REM sleep behavior disorder in Japanese patients with Parkinson's disease: a multicenter study using the REM sleep behavior disorder screening questionnaire | Q34246009 | ||
Predictors of dementia in Parkinson disease: a prospective cohort study | Q34269001 | ||
Risk of sleep-disordered breathing in Parkinson's disease | Q34299945 | ||
Application of LSVT BIG intervention to address gait, balance, bed mobility, and dexterity in people with Parkinson disease: a case series. | Q34405789 | ||
Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management | Q34442089 | ||
Abnormal metabolic network activity in REM sleep behavior disorder | Q37658353 | ||
REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease. | Q37716114 | ||
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients | Q37733321 | ||
Scales to assess sleep impairment in Parkinson's disease: critique and recommendations | Q37798777 | ||
Testing an aetiological model of visual hallucinations in Parkinson's disease | Q37932878 | ||
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic | Q38039066 | ||
Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction | Q38191304 | ||
Nocturnal journey of body and mind in Parkinson's disease: the manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study | Q38200511 | ||
Meta-analysis of the efficacy and safety of long-acting non-ergot dopamine agonists in Parkinson's disease | Q38208548 | ||
Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease | Q38381821 | ||
Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study | Q38386657 | ||
Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia | Q38387848 | ||
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD. | Q39051901 | ||
Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG. | Q39159897 | ||
Investigating rapid eye movement sleep without atonia in Parkinson's disease using the rapid eye movement sleep behavior disorder screening questionnaire | Q39233404 | ||
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose | Q39336078 | ||
Prevalence of nocturia in Parkinson's disease patients from various ethnicities. | Q39344081 | ||
Idiopathic Parkinson's disease patients at the urologic clinic | Q39377678 | ||
Plasma urate in REM sleep behavior disorder | Q39444007 | ||
Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study. | Q39446817 | ||
Visual symptoms in Parkinson's disease and Parkinson's disease dementia. | Q39703424 | ||
Sleep disorders in Chinese patients with Parkinson's disease: validation study of a Chinese version of Parkinson's disease sleep scale | Q40087084 | ||
Nighttime sleep problems and daytime sleepiness in Parkinson's disease | Q40160509 | ||
Sleep disturbances in drug naïve Parkinson's disease (PD) patients and effect of levodopa on sleep | Q41691668 | ||
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson’s disease | Q42810802 | ||
The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia | Q42875934 | ||
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. | Q42905495 | ||
Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease | Q42905506 | ||
Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease. | Q42957249 | ||
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment | Q43057272 | ||
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects | Q43255320 | ||
Nonviolent elaborate behaviors may also occur in REM sleep behavior disorder | Q43367728 | ||
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy. | Q43591473 | ||
Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease | Q43608778 | ||
Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease | Q43786637 | ||
Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time | Q43850425 | ||
Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters. | Q43935742 | ||
Rapid eye movement sleep behavior disorder in treatment-naïve Parkinson disease patients | Q43946880 | ||
Characteristics of obstructive sleep apnea in patients with Parkinson's disease | Q44038772 | ||
Sleepwalking, REM sleep behaviour disorder and overlap parasomnia in patients with Parkinson's disease | Q44049630 | ||
Depression and quality of life in monogenic compared to idiopathic, early-onset Parkinson's disease | Q44073890 | ||
SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease | Q44153415 | ||
Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease. | Q44183770 | ||
Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease | Q48640356 | ||
The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease | Q48651091 | ||
Quality of life in young- compared with late-onset Parkinson's disease | Q48669290 | ||
Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy | Q48686296 | ||
The relation of falls to fatigue, depression and daytime sleepiness in Parkinson's disease | Q48686419 | ||
Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome | Q48741928 | ||
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression | Q48805917 | ||
Psychometric evaluation of the Stanford Sleepiness Scale | Q48887333 | ||
Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness. | Q48944618 | ||
"Saw-tooth" pattern in the flow-volume loop | Q49036432 | ||
A "saw-tooth" pattern in Parkinson's disease | Q49054119 | ||
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia | Q50216645 | ||
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. | Q50725140 | ||
Prevalence and clinical profile of restless legs syndrome in Parkinson's disease | Q51545647 | ||
Evaluation of fatigue in Parkinson's disease using the Brazilian version of Parkinson's Fatigue Scale. | Q51566657 | ||
Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease. | Q51650199 | ||
Fatigue in a cohort of geriatric patients with and without Parkinson's disease. | Q51865199 | ||
Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease | Q56688228 | ||
Transdermal Rotigotine | Q56688229 | ||
Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole | Q56971074 | ||
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results | Q57083753 | ||
Assessing autonomic symptoms of Parkinson’s disease with the SCOPA-AUT: a new perspective from Rasch analysis | Q60222446 | ||
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients | Q62719833 | ||
Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson's disease | Q80235684 | ||
Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson's disease | Q83021601 | ||
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension study | Q83425577 | ||
Validation of the non-motor symptoms questionnaire (NMS-Quest) | Q84943707 | ||
Abnormal ventilatory control in Parkinson's disease--further evidence for non-motor dysfunction | Q85063984 | ||
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's disease | Q86424776 | ||
Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease | Q88060366 | ||
Impaired visual perception in rapid eye movement sleep behavior disorder | Q48145448 | ||
Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease | Q48160062 | ||
Transcranial brain sonography in Parkinson's disease with restless legs syndrome | Q48167362 | ||
Drivers with Parkinson's disease: are the symptoms of PD associated with restricted driving practices? | Q48167887 | ||
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease | Q48172368 | ||
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies | Q48172943 | ||
Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease | Q48187731 | ||
Sleep disturbance in patients with Parkinson's disease presenting with leg motor restlessness | Q48190257 | ||
Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease | Q48190381 | ||
Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study | Q48199609 | ||
Motor and non-motor symptoms in Turkish patients with Parkinson's disease affecting family caregiver burden and quality of life | Q48207453 | ||
Validation of the Innsbruck REM sleep behavior disorder inventory | Q48209401 | ||
Abnormal occipital event-related potentials in Parkinson's disease with concomitant REM sleep behavior disorder | Q48215461 | ||
Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study | Q48227407 | ||
Sleep matters in Parkinson's disease: use of a priority list to assess the presence of sleep disturbances | Q48227572 | ||
Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease? | Q48230826 | ||
Subjective sleep problems in patients with early Parkinson's disease | Q48235902 | ||
Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness? | Q48235911 | ||
Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease | Q48236738 | ||
REM sleep behavior disorder in Parkinson's disease--is there a gender difference? | Q48237112 | ||
How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder | Q48245989 | ||
Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2. | Q48247525 | ||
A preliminary quantitative analysis of REM sleep chin EMG in Parkinson's disease with or without REM sleep behavior disorder. | Q48252779 | ||
Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson's disease. | Q48252870 | ||
Heart rate variability in patients with idiopathic Parkinson's disease with and without obstructive sleep apnea syndrome | Q48256696 | ||
Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study | Q48259289 | ||
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients | Q48259976 | ||
Increased risk of leg motor restlessness but not RLS in early Parkinson disease | Q48274480 | ||
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. | Q48275749 | ||
Complex paroxysmal nocturnal behaviors in Parkinson's disease | Q48285785 | ||
Associated factors for REM sleep behavior disorder in Parkinson disease | Q48288948 | ||
The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease | Q48289765 | ||
Fatigue in patients with Parkinson's disease: impact on quality of life | Q48290623 | ||
Slowing of electroencephalogram in rapid eye movement sleep behavior disorder | Q48291939 | ||
Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study | Q48293141 | ||
Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease | Q48296062 | ||
Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease | Q48296473 | ||
Towards an understanding of fatigue in Parkinson disease | Q48298647 | ||
The impact of sleep and mood disorders on quality of life in Parkinson's disease patients | Q48301186 | ||
Relationship between sleep and dysautonomic symptoms assessed by self-report scales. | Q48303345 | ||
Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder | Q48304705 | ||
Validation of the Thai SCOPA-sleep scale for assessment of sleep and sleepiness in patients with Parkinson's disease. | Q48304949 | ||
Neuropsychological functioning in Parkinson's disease: differential relationships with self-reported sleep-wake disturbances | Q48308858 | ||
Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease | Q48308907 | ||
Probable REM sleep behaviour disorder and STN-DBS outcome in Parkinson's Disease | Q48309179 | ||
Effect of chronic kidney disease on excessive daytime sleepiness in Parkinson disease | Q48310921 | ||
How well do we recognise non-motor symptoms in a British Parkinson's disease population? | Q48312842 | ||
Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). | Q48316901 | ||
Parkinson's disease sleep scale--validation of the revised version PDSS-2. | Q48317345 | ||
The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease | Q48319936 | ||
Relation between subtype of Parkinson's disease and REM sleep behavior disorder | Q36955210 | ||
No increased risk of obstructive sleep apnea in Parkinson's disease | Q37056523 | ||
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease | Q37056546 | ||
Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease | Q37060398 | ||
Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks | Q37071647 | ||
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder | Q37100913 | ||
The impact of sleep quality on cognitive functioning in Parkinson's disease | Q37136554 | ||
Daytime sleepiness is associated with falls in Parkinson's disease | Q37170504 | ||
A controlled trial of antidepressants in patients with Parkinson disease and depression | Q37180389 | ||
Effects of sleep disorders on the non-motor symptoms of Parkinson disease | Q37248911 | ||
Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities | Q37248917 | ||
Nocturia and overnight polysomnography in Parkinson disease | Q37255541 | ||
A comprehensive model of health-related quality of life in Parkinson's disease. | Q37280767 | ||
Sleep and impulsivity in Parkinson's disease | Q37425362 | ||
Restless legs syndrome and its associated risk factors in Parkinson's disease | Q37433288 | ||
Restless legs syndrome: an early clinical feature of Parkinson disease in men. | Q37510441 | ||
Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea | Q37518484 | ||
Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease? | Q37576274 | ||
A Neurodegenerative Disease Sleep Questionnaire: principal component analysis in Parkinson's disease | Q37625684 | ||
Associations of sleep disturbance symptoms with health-related quality of life in Parkinson's disease | Q37651800 | ||
Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study | Q37657040 | ||
What are obstructive sleep apnea patients being treated for prior to this diagnosis? | Q34498263 | ||
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study | Q34508280 | ||
Lack of polysomnographic Non-REM sleep changes in early Parkinson's disease | Q34548263 | ||
Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire | Q34581337 | ||
REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. | Q34581908 | ||
Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. | Q34585382 | ||
Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease? | Q34610885 | ||
Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS | Q34617020 | ||
Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial | Q34619438 | ||
Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms | Q34638941 | ||
Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease. | Q34651186 | ||
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities | Q34666836 | ||
The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument | Q34692883 | ||
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). | Q34771200 | ||
Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). | Q35014993 | ||
Nonmotor symptoms groups in Parkinson's disease patients: results of a pilot, exploratory study | Q35028869 | ||
Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson disease. | Q35058875 | ||
Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome | Q35059012 | ||
Sleep quality in Parkinson disease: an examination of clinical variables | Q35078570 | ||
Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients | Q35107980 | ||
Actigraphy as a diagnostic aid for REM sleep behavior disorder in Parkinson's disease | Q35141127 | ||
Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial | Q35485478 | ||
The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease | Q35560075 | ||
Clinical correlates of periodic limb movements in sleep in Parkinson's disease | Q35874812 | ||
Caffeine for treatment of Parkinson disease: a randomized controlled trial | Q36149963 | ||
Insomnia in Parkinson's disease: frequency and progression over time | Q36227480 | ||
Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population | Q36380042 | ||
Daytime REM sleep in Parkinson's disease | Q36451550 | ||
REM sleep behavior disorder in Parkinson's disease: a questionnaire-based survey | Q36477085 | ||
Sleep in essential tremor: a comparison with normal controls and Parkinson's disease patients | Q36610164 | ||
Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder | Q36626762 | ||
The spectrum of nonmotor symptoms in early Parkinson disease | Q36659353 | ||
Non-motor symptoms of Parkinson's disease: the patient's perspective | Q36725177 | ||
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER. | Q36941752 | ||
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease | Q36953865 | ||
The role of mild depression in sleep disturbance and quality of life in Parkinson's disease | Q44220201 | ||
Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorder | Q44238309 | ||
Evaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease | Q44308213 | ||
Sleep disturbances in untreated Parkinson's disease. | Q44499646 | ||
Revisiting the impact of REM sleep behavior disorder on motor progression in Parkinson's disease | Q44511600 | ||
Sleep benefit in Parkinson's disease is associated with short sleep times | Q44569386 | ||
Actigraphically-defined sleep disturbance in Parkinson's disease is associated with differential aspects of cognitive functioning | Q44597462 | ||
Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies | Q44613423 | ||
Correlates of excessive daytime sleepiness in Parkinson's disease | Q44619342 | ||
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. | Q44825538 | ||
Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life | Q44826435 | ||
Association of pain, Parkinson's disease, and restless legs syndrome | Q44904610 | ||
Bladder dysfunction in advanced Parkinson's disease. | Q44925060 | ||
Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease? | Q45076738 | ||
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off | Q45122889 | ||
A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease | Q45179908 | ||
Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease | Q45205196 | ||
Excessive daytime sleepiness and its risk factors in incident Parkinson's disease | Q45345054 | ||
Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder | Q45428915 | ||
No association between neuropathy and restless legs in Parkinson's disease | Q45738852 | ||
Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency | Q45740995 | ||
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms | Q45749080 | ||
RBD in Parkinson's disease: a clinical case control study from North India | Q45815060 | ||
Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage | Q46153566 | ||
Psychotic and compulsive symptoms in Parkinson's disease. | Q46169445 | ||
Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study | Q46330976 | ||
Circadian rest-activity rhythm is altered in Parkinson's disease patients with hallucinations | Q46354633 | ||
Snoring is associated with an impaired motor function, disease severity and the quality of life but not with excessive daytime sleepiness in patients with Parkinson's disease. | Q46464356 | ||
REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features | Q46488410 | ||
Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease | Q46627313 | ||
Lower urinary tract symptoms in men with Parkinson disease | Q46630485 | ||
Melatonin for sleep disturbances in Parkinson's disease | Q46637940 | ||
Sudden uncontrollable somnolence and medication use in Parkinson disease | Q46640925 | ||
Rapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging study | Q46770992 | ||
Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease | Q46924171 | ||
Predictive factors for nocturia in elderly men: a cross-sectional study in 21 general practices | Q46936658 | ||
The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome | Q46962027 | ||
Restoration of normal motor control in Parkinson's disease during REM sleep | Q47582710 | ||
Polysomnographic predictors of blood pressure and hypertension: is one index best? | Q47697429 | ||
Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients | Q47766482 | ||
Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson's disease patients | Q47782385 | ||
Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease | Q48005952 | ||
Impulse control disorder and rapid eye movement sleep behavior disorder in Parkinson's disease | Q48025528 | ||
Parasomnias and isolated sleep symptoms in Parkinson's disease: a questionnaire study on 661 patients | Q48031472 | ||
Association between nocturnal/supine hypertension and restless legs syndrome in patients with Parkinson's disease | Q48094556 | ||
Clinical features associated with sleep disturbances in Parkinson's disease | Q48094582 | ||
Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder | Q48095208 | ||
Reduced thalamic volume in Parkinson disease with REM sleep behavior disorder: volumetric study | Q48095600 | ||
Patient-reported autonomic symptoms in Parkinson disease | Q48097601 | ||
Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder | Q48320944 | ||
Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures. | Q48322948 | ||
Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial | Q48324346 | ||
Cardiac 123I-MIBG accumulation in Parkinson's disease differs in association with REM sleep behavior disorder | Q48326527 | ||
REM behaviour disorder detection associated with neurodegenerative diseases | Q48330499 | ||
Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease | Q48336115 | ||
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? | Q48337791 | ||
Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease | Q48340392 | ||
A 12-year population-based study of psychosis in Parkinson disease | Q48345449 | ||
Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder | Q48347012 | ||
Parkinson's disease symptoms: the patient's perspective | Q48349277 | ||
REM sleep behavior disorder is not linked to postural instability and gait dysfunction in Parkinson | Q48349296 | ||
Sleep patterns in Parkinson's disease patients with visual hallucinations | Q48350404 | ||
Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep | Q48351864 | ||
Lower prevalence of sleep disturbances in familial versus sporadic Parkinson's disease: a questionnaire based study | Q48354473 | ||
Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants | Q48374408 | ||
Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia | Q48382930 | ||
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia | Q48384242 | ||
Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and Polysomnography | Q48386386 | ||
REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream? | Q48386776 | ||
Malnutrition and associated factors in Chinese patients with Parkinson's disease: Results from a pilot investigation | Q48387106 | ||
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease | Q48391906 | ||
Is obstructive sleep apnea a problem in Parkinson's disease? | Q48393802 | ||
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease | Q48398056 | ||
Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS. | Q48403662 | ||
Patterns of motor and non-motor features in Parkinson's disease. | Q48409698 | ||
Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version | Q48409726 | ||
Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences? | Q48413323 | ||
Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy | Q48420586 | ||
Manifestations of Parkinson disease differ in association with REM sleep behavior disorder | Q48426386 | ||
Predictors and course of health-related quality of life in Parkinson's disease | Q48433831 | ||
REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. | Q48433835 | ||
STOP questionnaire: a tool to screen patients for obstructive sleep apnea | Q48436814 | ||
Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease | Q48439627 | ||
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms | Q48440050 | ||
Nonmotor symptoms of Parkinson's disease: prevalence and awareness of patients and families | Q48450074 | ||
The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease | Q48450083 | ||
Excessive daytime sleepiness in Parkinson disease: a SPECT study | Q48452421 | ||
Case-control study of restless legs syndrome and quality of sleep in Parkinson's disease | Q48454144 | ||
Restless legs syndrome in Parkinson's disease | Q48464367 | ||
Characteristics of sleep disturbances in Japanese patients with Parkinson's disease. A study using Parkinson's disease sleep scale | Q48466407 | ||
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France | Q48467673 | ||
Bright light therapy in Parkinson's disease: a pilot study | Q48468410 | ||
Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study | Q48473078 | ||
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease | Q48473116 | ||
Measurement properties and hierarchical item structure of the Epworth Sleepiness Scale in Parkinson's disease | Q48476633 | ||
Driving with distraction in Parkinson disease | Q48484285 | ||
Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease | Q48485654 | ||
Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? | Q48490629 | ||
Mood and sleep in Parkinson's disease. | Q48494938 | ||
P921 | main subject | systematic review | Q1504425 |
sleep | Q35831 | ||
Parkinson's disease | Q11085 | ||
P304 | page(s) | 33-50 | |
P577 | publication date | 2016-08-31 | |
P1433 | published in | Sleep Medicine Reviews | Q15716616 |
P1476 | title | A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015 | |
P478 | volume | 35 |
Q64863522 | Q64863522 |
Q64865258 | Q64865258 |
Q64878090 | Q64878090 |
Q90470076 | A 10-Year Follow-Up of Excessive Daytime Sleepiness in Parkinson's Disease |
Q41501356 | A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD). |
Q91738117 | Association between circadian rhythms and neurodegenerative diseases |
Q55456108 | Circadian and Homeostatic Modulation of Multi-Unit Activity in Midbrain Dopaminergic Structures. |
Q58760662 | Clinical Predictors of Excessive Daytime Sleepiness in Patients with Parkinson's Disease |
Q38647726 | Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series. |
Q58700828 | Deep Brain Stimulation and Sleep-Wake Disturbances in Parkinson Disease: A Review |
Q47753232 | Diagnostic accuracy of REM sleep behaviour disorder screening questionnaire: a meta-analysis |
Q53406124 | Disturbances of Sleep and Alertness in Parkinson's Disease. |
Q55618860 | Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany? |
Q47657737 | Effects of Exercise on Non-motor Symptoms in Parkinson's Disease |
Q90174256 | Effects of sleep disruption on stress, nigrostriatal markers, and behavior in a chronic/progressive MPTP male mouse model of parkinsonism |
Q52583507 | Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management. |
Q64867863 | Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men |
Q90203947 | Factors related to sleep disturbances for individuals with Parkinson's disease: a regional perspective |
Q88687003 | Idiopathic Hypersomnia |
Q90325236 | Initiation of pharmacological therapy in Parkinson's disease: when, why, and how |
Q38758058 | Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease |
Q57454213 | Low-Grade Inflammation Aggravates Rotenone Neurotoxicity and Disrupts Circadian Clock Gene Expression in Rats |
Q94561297 | Nonmotor Symptoms Affect Sleep Quality in Early-Stage Parkinson's Disease Patients With or Without Cognitive Dysfunction |
Q47204114 | Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients |
Q90186870 | Presleep Cognitive Arousal and Insomnia Comorbid to Parkinson Disease: Evidence for a Serial Mediation Model of Sleep-Related Safety Behaviors and Dysfunctional Beliefs About Sleep |
Q94586424 | REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes |
Q64780258 | Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease |
Q33634088 | Retinal Ganglion Cells and Circadian Rhythms in Alzheimer's Disease, Parkinson's Disease, and Beyond |
Q41620763 | Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now? |
Q97886916 | Rpt2 proteasome subunit reduction causes Parkinson's disease like symptoms in Drosophila |
Q47659714 | SLEEP AND CIRCADIAN RHYTHM DISORDERS IN PARKINSON'S DISEASE. |
Q99414223 | Shedding Light on Nocturnal Movements in Parkinson's Disease: Evidence from Wearable Technologies |
Q54947557 | Sleep Disorders in Parkinson's Disease: Present Status and Future Prospects. |
Q92947665 | Sleep Disturbance as Potential Risk and Progression Factor for Parkinson's Disease |
Q91633928 | Sleep and risk of parkinsonism and Parkinson's disease: a population-based study |
Q55221111 | Sleep disturbances and depression severity in patients with Parkinson's disease. |
Q92988505 | Sleep in Parkinson's disease |
Q47223743 | Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial. |
Q57485185 | Spatial disorientation and executive dysfunction in elderly nondemented patients with Parkinson's disease |
Q93013689 | Striatum Shape Hypertrophy in Early Stage Parkinson's Disease With Excessive Daytime Sleepiness |
Q64767243 | The Parkinson's Disease Sleep Scale-2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version |
Q39342961 | Treatment of Sleep Dysfunction in Parkinson's Disease. |
Q64108391 | White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness |
Search more.